{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:21:19Z","timestamp":1793334079656,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473894"],"award-info":[{"award-number":["82473894"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LD22H310004"],"award-info":[{"award-number":["LD22H310004"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.canlet.2026.218621","type":"journal-article","created":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T13:53:06Z","timestamp":1779630786000},"page":"218621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Repurposing the Neurokinin-1 receptor antagonist Aprepitant to eradicate relapsed\/refractory acute lymphoblastic leukemia via mitochondria-driven necroptosis"],"prefix":"10.1016","volume":"656","author":[{"given":"Gang","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanling","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanfang","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xurui","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruitao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmin","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huafeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4090-885X","authenticated-orcid":false,"given":"Caiyun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218621_bib3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13045-021-01060-y","article-title":"Targeting chemokines for acute lymphoblastic leukemia therapy","volume":"14","author":"Hong","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2026.218621_bib4","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0140-6736(25)00864-5","article-title":"Acute lymphocytic leukaemia","volume":"406","author":"Kantarjian","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2026.218621_bib5","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.3390\/ijms23063067","article-title":"Resistance mechanisms in pediatric B-Cell acute lymphoblastic leukemia","volume":"23","author":"J\u0119draszek","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218621_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1631\/jzus.B2300455","article-title":"Advances in the research and application of neurokinin-1 receptor antagonists","volume":"25","author":"Hong","year":"2024","journal-title":"J. Zhejiang Univ. - Sci. B"},{"key":"10.1016\/j.canlet.2026.218621_bib1","doi-asserted-by":"crossref","first-page":"19635","DOI":"10.1073\/pnas.1908998116","article-title":"Neurokinin-1 receptor is an effective target for treating leukemia by inducing oxidative stress through mitochondrial calcium overload","volume":"116","author":"Ge","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218621_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202101936","article-title":"A novel mechanism of endoplasmic reticulum Stress- and c-Myc-Degradation-Mediated therapeutic benefits of Antineurokinin-1 receptor drugs in colorectal cancer","volume":"8","author":"Shi","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.canlet.2026.218621_bib7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10637-010-9594-0","article-title":"The NK-1 receptor is expressed in human leukemia and is involved in the antitumor action of aprepitant and other NK-1 receptor antagonists on acute lymphoblastic leukemia cell lines","volume":"30","author":"Mu\u00f1oz","year":"2012","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.canlet.2026.218621_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105297","article-title":"Necrostatin-1 and necroptosis inhibition: pathophysiology and therapeutic implications","volume":"163","author":"Cao","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.canlet.2026.218621_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aat2738","article-title":"Chemical disruption of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis","volume":"3","author":"Rathkey","year":"2018","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.canlet.2026.218621_bib10","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1182\/blood-2004-07-2870","article-title":"z-VAD-fmk augmentation of TNF alpha-stimulated neutrophil apoptosis is compound specific and does not involve the generation of reactive oxygen species","volume":"105","author":"Cowburn","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2026.218621_bib11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s11658-020-00205-0","article-title":"Ferrostatin-1 alleviates lipopolysaccharide-induced acute lung injury via inhibiting ferroptosis","volume":"25","author":"Liu","year":"2020","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.canlet.2026.218621_bib12","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1080\/15548627.2015.1066957","article-title":"Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and Ca-P60A\/SERCA-dependent autophagosome-lysosome fusion","volume":"11","author":"Mauvezin","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2026.218621_bib13","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1080\/15548627.2018.1474314","article-title":"Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion","volume":"14","author":"Mauthe","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2026.218621_bib14","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1182\/blood-2007-01-067785","article-title":"Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone","volume":"110","author":"Choi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2026.218621_bib15","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41586-023-06342-8","article-title":"Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells","volume":"620","author":"Goyal","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218621_bib16","first-page":"1934","article-title":"Relapsed childhood T-cell acute lymphoblastic leukemia and lymphoblastic lymphoma","volume":"110","author":"Hughes","year":"2025","journal-title":"Haematologica"},{"key":"10.1016\/j.canlet.2026.218621_bib17","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/13543776.2020.1769599","article-title":"Neurokinin receptor antagonism: a patent review (2014-present)","volume":"30","author":"Mu\u00f1oz","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.canlet.2026.218621_bib18","doi-asserted-by":"crossref","DOI":"10.1172\/JCI179570","article-title":"Targeting apoptotic pathways for cancer therapy","volume":"134","author":"Tian","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218621_bib19","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/s41568-025-00836-5","article-title":"Endoplasmic reticulum stress responses in anticancer immunity","volume":"25","author":"Hwang","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218621_bib20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.semcancer.2015.04.003","article-title":"ER proteostasis addiction in cancer biology: novel concepts","volume":"33","author":"Dufey","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2026.218621_bib21","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/cvr\/cvac134","article-title":"Mitochondrial calcium and reactive oxygen species in cardiovascular disease","volume":"119","author":"Murphy","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.canlet.2026.218621_bib22","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1073\/pnas.1200012109","article-title":"Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis","volume":"109","author":"Zhao","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.canlet.2026.218621_bib23","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1634\/theoncologist.2014-0229","article-title":"Aprepitant and fosaprepitant: a 10-year review of efficacy and safety","volume":"20","author":"Aapro","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/j.canlet.2026.218621_bib24","article-title":"Fexofenadine overcomes osimertinib resistance by inhibiting c-Met in non-small cell lung cancer","volume":"4","author":"To","year":"2025","journal-title":"MedComm Oncol."},{"key":"10.1016\/j.canlet.2026.218621_bib25","article-title":"Colorectal Cancer Cells Promote de novo Glycine Synthesis for Collagen Production in Cancer-Associated Fibroblasts by Secreting TGF-\u03b21","volume":"4","author":"Liu","year":"2025","journal-title":"MedComm Oncol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526003848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526003848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:23:15Z","timestamp":1783437795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526003848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":25,"alternative-id":["S0304383526003848"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218621","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing the Neurokinin-1 receptor antagonist Aprepitant to eradicate relapsed\/refractory acute lymphoblastic leukemia via mitochondria-driven necroptosis","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218621","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218621"}}